ELVANSE

Main information

  • Trade name:
  • ELVANSE Capsule, hard 50MG
  • Dosage:
  • 50MG
  • Pharmaceutical form:
  • Capsule, hard
  • Administration route:
  • Oral use
  • Units in package:
  • 30 Tablet container
  • Prescription type:
  • with prescription
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • ELVANSE Capsule, hard 50MG
    Czech Republic
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • LISDEXAMFETAMIN
  • Product summary:
  • ELVANSE

Other information

Status

  • Source:
  • SUKL - Státní ústav pro kontrolu léčiv
  • Authorization status:
  • R - active MA/authorised medicinal product
  • Authorization number:
  • 06/ 083/16-C
  • Last update:
  • 04-04-2018

There are no safety alerts related to this product.

11-6-2018

Pradaxa (Boehringer Ingelheim International GmbH)

Pradaxa (Boehringer Ingelheim International GmbH)

Pradaxa (Active substance: dabigatran etexilate mesilate) - Centralised - 2-Monthly update - Commission Decision (2018)3755 of Mon, 11 Jun 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/829/II/108

Europe -DG Health and Food Safety